We performed a study to estimate the point prevalence of progressive supranuclear palsy (PSP) in the UK at national, regional and community levels. A 'Russian doll' design was used in which the population denominator for each of the three studies was successively smaller, whilst the method of case ascertainment became increasingly more rigorous. The NINDS-SPSP (National Institute of Neurological Disorders and the Society for Progressive Supranuclear Palsy) diagnostic criteria for PSP were applied throughout the study for case definition. The national study identified cases using passive referral mechanisms [e.g. the British Neurological Surveillance Unit (BNSU), PSP (Europe) Association patient register]. We identified 577 cases of PSP, giv...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnos...
We performed a study to estimate the point prevalence of progressive supranuclear palsy (PSP) in the...
Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder and no ...
Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little ...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Sixty years ago, Steele, Richardson and Olszewski designated progressive supranuclear palsy (PSP) as...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
Available from British Library Document Supply Centre- DSC:DXN055336 / BLDSC - British Library Docum...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
International audienceObjective: To describe a cluster of progressive supranuclear palsy (PSP) in no...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Progressive supranuclear palsy (PSP) belongs to the disease spectrum of Parkinsonian syndromes. Due ...
Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy int...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnos...
We performed a study to estimate the point prevalence of progressive supranuclear palsy (PSP) in the...
Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder and no ...
Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little ...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Sixty years ago, Steele, Richardson and Olszewski designated progressive supranuclear palsy (PSP) as...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
Available from British Library Document Supply Centre- DSC:DXN055336 / BLDSC - British Library Docum...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
International audienceObjective: To describe a cluster of progressive supranuclear palsy (PSP) in no...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Progressive supranuclear palsy (PSP) belongs to the disease spectrum of Parkinsonian syndromes. Due ...
Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy int...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnos...